Clinical Trial Update: Role of Statin Therapy in Prevention of Anthracycline-Induced Cardiotoxicity [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update examines the role of statin therapy in preventing anthracycline-induced cardiotoxicity, evaluated in Phase 2 and Phase 3 stages.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Doxorubicin-induced Cardiomyopathy

Snippet

Sponsor: Ain Shams University | Conditions: Doxorubicin Induced Cardiomyopathy | Phase 2, Phase 3 | Status: UNKNOWN